Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 46Triple Negative Breast Neoplasms 4Carcinoma, Intraductal, Noninfiltrating 3Recurrence 2Unilateral Breast Neoplasms 1Pain 1Neoplasms 1Lymphedema 1Li-Fraumeni Syndrome 1Inflammation 1Hamartoma Syndrome, Multiple 1Cystic Fibrosis 1Carcinoma, Ductal, Breast 1Breast Carcinoma In Situ 1Breast Cancer Invasive 1Breast Cancer Female 1Anatomic Stage II Breast Cancer AJCC v8 1

Interventions

Cyclophosphamide 155Dexamethasone 141Rituximab 85fludarabine 80Lenalidomide 72Cytarabine 70Bortezomib 65fludarabine phosphate 63Gemcitabine 62venetoclax 55pomalidomide 53Etoposide 53pembrolizumab 52Paclitaxel 48Cisplatin 48Carboplatin 48Peripheral Blood Stem Cell Transplantation 47Filgrastim 40Radiotherapy 39Busulfan 37Calcium Dobesilate 36Methotrexate 34Melphalan 34Bevacizumab 33carfilzomib 32Cyclosporine 32Azacitidine 32Mycophenolic Acid 30Vincristine 29Bendamustine Hydrochloride 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recurrence × Mastectomy × Clear all
NCT06704659 2026-03-09

RAY-no-BAN

Turku University Hospital

Phase NA Recruiting
60 enrolled
Breast

Breast Neoplasms, Recurrence

NCT02464774 2015-06-08

Breast-Conserving Therapy in Patients With Triple-Negative Breast Cancer

Sun Yat-sen University

Phase NA Unknown
464 enrolled
Breast

Breast Neoplasms, Recurrence, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡